Invention Grant
- Patent Title: Anti-CS1 antibodies and antibody drug conjugates
-
Application No.: US15819153Application Date: 2017-11-21
-
Publication No.: US10308713B2Publication Date: 2019-06-04
- Inventor: Kurt C. Gish , Han K. Kim , Louie Naumovski
- Applicant: AbbVie Biotherapeutics Inc.
- Applicant Address: US CA Redwood City
- Assignee: AbbVie Biotherapeutics Inc.
- Current Assignee: AbbVie Biotherapeutics Inc.
- Current Assignee Address: US CA Redwood City
- Agency: Dechert LLP
- Main IPC: A61K45/06
- IPC: A61K45/06 ; C07K16/28 ; A61K47/68 ; A61K31/454 ; A61K31/573 ; A61K31/69 ; A61K31/704 ; A61K39/395 ; A61K39/00
Abstract:
The present disclosure provides antibodies and antibody drug conjugates that bind human CS1 and their uses to treat subjects diagnosed with a plasma cell neoplasm, for example, multiple myeloma.
Public/Granted literature
- US20180222979A1 ANTI-CS1 ANTIBODIES AND ANTIBODY DRUG CONJUGATES Public/Granted day:2018-08-09
Information query
